Title : Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

Pub. Date : 2010 Aug 1

PMID : 20567009






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After 7.8 mean years of follow-up (standard deviation, 1.7), invasive breast cancer incidence was lower in bisphosphonate users (hazard ratio [HR], 0.68; 95% CI, 0.52 to 0.88; P < .01) as was incidence of estrogen receptor (ER) -positive invasive cancers (HR, 0.70; 95% CI, 0.52 to 0.94, P = .02). Diphosphonates estrogen receptor 1 Homo sapiens
2 After 7.8 mean years of follow-up (standard deviation, 1.7), invasive breast cancer incidence was lower in bisphosphonate users (hazard ratio [HR], 0.68; 95% CI, 0.52 to 0.88; P < .01) as was incidence of estrogen receptor (ER) -positive invasive cancers (HR, 0.70; 95% CI, 0.52 to 0.94, P = .02). Diphosphonates estrogen receptor 1 Homo sapiens